alendronate has been researched along with Libman-Sacks Disease in 8 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of alendronate (Alen) on the prevention of systemic glucocorticoid-induced osteoporosis in patients with rheumatic diseases." | 9.13 | [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases]. ( Huang, YL; Wang, QH; Wen, LH; Wu, HX; Xue, J; Yang, XY; Zhu, L, 2008) |
| "To investigate the effects of alendronate (Alen) on the prevention of systemic glucocorticoid-induced osteoporosis in patients with rheumatic diseases." | 5.13 | [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases]. ( Huang, YL; Wang, QH; Wen, LH; Wu, HX; Xue, J; Yang, XY; Zhu, L, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Uzuncakmak, TK | 1 |
| Bayazit, S | 1 |
| Askin, O | 1 |
| Engin, B | 1 |
| Ugurlu, S | 1 |
| Sar, M | 1 |
| Serdaroglu, S | 1 |
| Wang, CJ | 1 |
| Cheng, JH | 1 |
| Huang, CC | 1 |
| Yip, HK | 1 |
| Russo, S | 1 |
| Yeap, SS | 2 |
| Fauzi, AR | 1 |
| Kong, NC | 1 |
| Halim, AG | 1 |
| Soehardy, Z | 1 |
| Rahimah, I | 1 |
| Chow, SK | 1 |
| Goh, EM | 1 |
| Wang, QH | 1 |
| Wu, HX | 1 |
| Huang, YL | 1 |
| Xue, J | 1 |
| Yang, XY | 1 |
| Zhu, L | 1 |
| Wen, LH | 1 |
| Othman, AZ | 1 |
| Zain, AA | 1 |
| Chan, SP | 1 |
| Fernandes, JL | 1 |
| Viana, SL | 1 |
| Rocha, AL | 1 |
| Ribeiro, MC | 1 |
| Castro, LC | 1 |
| Rudge, S | 1 |
| Hailwood, S | 1 |
| Horne, A | 1 |
| Lucas, J | 1 |
| Wu, F | 1 |
| Cundy, T | 1 |
| Agarwala, S | 1 |
| Sule, A | 1 |
| Pai, BU | 1 |
| Joshi, VR | 1 |
1 review available for alendronate and Libman-Sacks Disease
| Article | Year |
|---|---|
Extracorporeal shockwave therapy for avascular necrosis of femoral head.
Topics: Alendronate; Bone Density Conservation Agents; Combined Modality Therapy; Femur Head Necrosis; High- | 2015 |
4 trials available for alendronate and Libman-Sacks Disease
| Article | Year |
|---|---|
A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Calcitr | 2008 |
[Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Topics: Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Female; Glucocorticoids; Humans; | 2008 |
Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
Topics: Absorptiometry, Photon; Adrenal Cortex Hormones; Adult; Alendronate; Asian People; Biomarkers; Bone | 2012 |
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
Topics: Administration, Oral; Adolescent; Alendronate; Arthritis, Juvenile; Body Height; Bone Density; Bone | 2005 |
3 other studies available for alendronate and Libman-Sacks Disease
| Article | Year |
|---|---|
Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.
Topics: Aged; Alendronate; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Cutaneous; Lup | 2020 |
Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases.
Topics: Alendronate; Arthritis, Juvenile; Bone Density; Bone Remodeling; Child; Diphosphonates; Humans; Lupu | 2004 |
Study of alendronate in avascular necrosis of bone.
Topics: Alendronate; Femur Head Necrosis; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Male; Ra | 2001 |